BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19482859)

  • 1. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.
    Bartosch C; Exposito MI; Lopes JM
    Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases.
    Iwasaki S; Sudo T; Miwa M; Ukita M; Morimoto A; Tamada M; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Sakuma Y; Mikami Y; Nishimura R
    Arch Gynecol Obstet; 2013 Aug; 288(2):385-91. PubMed ID: 23435725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
    Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
    Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.
    Feng W; Hua K; Gudlaugsson E; Yu Y; Zhou X; Baak JP
    Histopathology; 2013 Apr; 62(5):675-87. PubMed ID: 23425310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
    Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
    Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
    Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
    Lee CH; Mariño-Enriquez A; Ou W; Zhu M; Ali RH; Chiang S; Amant F; Gilks CB; van de Rijn M; Oliva E; Debiec-Rychter M; Dal Cin P; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 May; 36(5):641-53. PubMed ID: 22456610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial stromal sarcoma: clinicopathological and immunophenotype study of 18 cases.
    Vera AA; Guadarrama MB
    Ann Diagn Pathol; 2011 Oct; 15(5):312-7. PubMed ID: 21652246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
    Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition from low-grade endometrial stromal sarcoma to high-grade endometrial stromal sarcoma.
    Ohta Y; Suzuki T; Omatsu M; Hamatani S; Shiokawa A; Kushima M; Ota H
    Int J Gynecol Pathol; 2010 Jul; 29(4):374-7. PubMed ID: 20567152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases.
    Kurihara S; Oda Y; Ohishi Y; Iwasa A; Takahira T; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
    Am J Surg Pathol; 2008 Aug; 32(8):1228-38. PubMed ID: 18580489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization.
    Halbwedl I; Ullmann R; Kremser ML; Man YG; Isadi-Moud N; Lax S; Denk H; Popper HH; Tavassoli FA; Moinfar F
    Gynecol Oncol; 2005 May; 97(2):582-7. PubMed ID: 15863163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
    Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
    Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
    Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sarcoma of the endometrial stroma].
    Melilli GA; Di Vagno G; Di Gesù A; Cormio G; Cazzolla A; Di Gesú G; Simonetti C
    Minerva Ginecol; 1998 Dec; 50(12):523-6. PubMed ID: 10069165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
    Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
    Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.